S&P 500   2,701.89 (+1.43%)
DOW   23,084.83 (+1.79%)
QQQ   198.43 (+0.99%)
AAPL   267.10 (+1.76%)
FB   168.83 (+1.98%)
MSFT   164.88 (-0.24%)
GOOGL   1,193.36 (+0.86%)
AMZN   2,016.00 (+0.92%)
CGC   14.94 (+4.18%)
NVDA   264.79 (-0.53%)
BABA   198.37 (+0.98%)
MU   46.18 (-0.41%)
GE   7.37 (+2.79%)
AMD   47.57 (+0.11%)
T   30.18 (+2.48%)
ACB   0.82 (+2.52%)
F   4.90 (+8.17%)
NFLX   372.94 (-1.85%)
BAC   22.09 (+3.27%)
GILD   74.09 (-4.68%)
DIS   103.32 (+3.75%)
S&P 500   2,701.89 (+1.43%)
DOW   23,084.83 (+1.79%)
QQQ   198.43 (+0.99%)
AAPL   267.10 (+1.76%)
FB   168.83 (+1.98%)
MSFT   164.88 (-0.24%)
GOOGL   1,193.36 (+0.86%)
AMZN   2,016.00 (+0.92%)
CGC   14.94 (+4.18%)
NVDA   264.79 (-0.53%)
BABA   198.37 (+0.98%)
MU   46.18 (-0.41%)
GE   7.37 (+2.79%)
AMD   47.57 (+0.11%)
T   30.18 (+2.48%)
ACB   0.82 (+2.52%)
F   4.90 (+8.17%)
NFLX   372.94 (-1.85%)
BAC   22.09 (+3.27%)
GILD   74.09 (-4.68%)
DIS   103.32 (+3.75%)
S&P 500   2,701.89 (+1.43%)
DOW   23,084.83 (+1.79%)
QQQ   198.43 (+0.99%)
AAPL   267.10 (+1.76%)
FB   168.83 (+1.98%)
MSFT   164.88 (-0.24%)
GOOGL   1,193.36 (+0.86%)
AMZN   2,016.00 (+0.92%)
CGC   14.94 (+4.18%)
NVDA   264.79 (-0.53%)
BABA   198.37 (+0.98%)
MU   46.18 (-0.41%)
GE   7.37 (+2.79%)
AMD   47.57 (+0.11%)
T   30.18 (+2.48%)
ACB   0.82 (+2.52%)
F   4.90 (+8.17%)
NFLX   372.94 (-1.85%)
BAC   22.09 (+3.27%)
GILD   74.09 (-4.68%)
DIS   103.32 (+3.75%)
S&P 500   2,701.89 (+1.43%)
DOW   23,084.83 (+1.79%)
QQQ   198.43 (+0.99%)
AAPL   267.10 (+1.76%)
FB   168.83 (+1.98%)
MSFT   164.88 (-0.24%)
GOOGL   1,193.36 (+0.86%)
AMZN   2,016.00 (+0.92%)
CGC   14.94 (+4.18%)
NVDA   264.79 (-0.53%)
BABA   198.37 (+0.98%)
MU   46.18 (-0.41%)
GE   7.37 (+2.79%)
AMD   47.57 (+0.11%)
T   30.18 (+2.48%)
ACB   0.82 (+2.52%)
F   4.90 (+8.17%)
NFLX   372.94 (-1.85%)
BAC   22.09 (+3.27%)
GILD   74.09 (-4.68%)
DIS   103.32 (+3.75%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 AlectorRegenxbioFate TherapeuticsCortexymeDenali Therapeutics
SymbolNASDAQ:ALECNASDAQ:RGNXNASDAQ:FATENASDAQ:CRTXNASDAQ:DNLI
Price Information
Current Price$23.94$30.84$24.61$39.54$18.74
52 Week RangeBuyBuyBuyHoldBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyHoldBuy
Consensus Price Target$28.00$76.75$35.44$34.25$29.67
% Upside from Price Target16.96% upside148.87% upside44.00% upside-13.38% downside58.31% upside
Trade Information
Market Cap$1.84 billion$1.16 billion$1.74 billion$1.03 billion$2.03 billion
Beta1.241.041.8N/A1.8
Average Volume574,707685,6431,563,486151,254667,759
Sales & Book Value
Annual Revenue$21.22 million$35.23 million$10.68 millionN/A$26.68 million
Price / Sales88.6032.51174.99N/A74.05
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$2.83 per share$12.23 per share$3.24 per share$4.30 per share$4.11 per share
Price / Book8.462.527.60N/A4.56
Profitability
Net Income$-105,390,000.00$-94,730,000.00$-98,150,000.00$-36,980,000.00$-197,610,000.00
EPS($1.71)($3.26)($1.44)($1.94)($2.07)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-496.65%-268.88%-919.00%N/A-740.74%
Return on Equity (ROE)-45.56%-25.21%-49.94%-43.38%-43.31%
Return on Assets (ROA)-22.85%-23.31%-36.92%-31.36%-32.00%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.21%0.02%0.10%N/A0.17%
Current Ratio5.77%10.25%8.17%11.93%9.48%
Quick Ratio5.77%10.25%8.17%11.93%9.48%
Ownership Information
Institutional Ownership Percentage53.54%80.84%95.07%27.03%67.08%
Insider Ownership Percentage13.90%13.80%21.41%N/A21.20%
Miscellaneous
Employees9119210416179
Shares Outstanding78.53 million37.14 million75.94 million29.40 million105.42 million
Next Earnings Date5/11/2020 (Estimated)5/5/2020 (Estimated)5/5/2020 (Estimated)6/10/2020 (Estimated)5/13/2020 (Estimated)
OptionableNot OptionableOptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel